SUBSCRIBE
SUBSCRIBE

Preclinical

Drug Development
World’s First Plastic Antibodies in Live Organisms: Stop Spread of Bee Venom in Mice, University of California, Irvine Study
June 22, 2010
 · 
1 min read
Drug Development
Stem Cell Therapy ‘Damage’ Seen in Kidney Disease Case, Chulalongkorn University and University of Toronto Study
June 18, 2010
 · 
1 min read
Drug Development
New Type of Human Stem Cell May Be Easier to Manipulate, Massachusetts General Hospital Study
June 11, 2010
 · 
2 min read
Drug Development
World’s First Plastic Antibody Works in Mice, University of California, Irvine Research
June 11, 2010
 · 
1 min read
Drug Development
University of Michigan’s Animal Study Reveals New Target for Antidepressants
June 2, 2010
 · 
1 min read
Drug Development
Chemo Plus Synthetic Drug JP1201 Shrunk Pancreatic Tumors, University of Texas Southwestern Medical Center Study
March 26, 2010
 · 
1 min read
DeMarc A. Hickson, of Jackson State University, UMMC, Jackson, Miss., shares his research on nocturnal blood pressure.
Drug Development
In Case You Missed It: AHA’s EPI / NPAM 2010 Joint Conference
March 13, 2010
 · 
9 min read
Drug Development
Novel Phosphodiesterase Inhibitor May Find Role in COPD, Orchid Research Laboratories Limited Study
March 3, 2010
 · 
1 min read
Bookmark and Share
Drug Development
Nanofiber Gel May Spur Growth of New Knee Cartilage, Northwestern University Study
February 5, 2010
 · 
1 min read
Bookmark and Share
Drug Development
Umbilical Cord Blood Stem Cell Transplant May Help Lung, Heart Disorders, Samsung Medical Center Study
November 30, 2009
 · 
1 min read
Load More
PRESS RELEASES
Drug Development
Q32 Bio Presents New Preclinical Data at the International Society of Nephrology Frontiers Meeting Demonstrating the Therapeutic Potential of ADX-097
June 23, 2022
 · 
3 min read
Drug Development
Omega Therapeutics to Present New Preclinical Data for the First Epigenomic Controller, OTX-2002, for Hepatocellular Carcinoma at the European Society of Medical Oncology’s 2022 World Congress on Gastrointestinal Cancer
June 23, 2022
 · 
6 min read
Drug Development
Pushing T cells down memory lane may improve cancer therapy
June 22, 2022
 · 
5 min read
Drug Development
Pliant Therapeutics Presents Preclinical Data Highlighting A Novel Approach for the Treatment of Muscular Dystrophies
June 22, 2022
 · 
5 min read
Drug Development
Rubius Therapeutics Presents Updated Data from its Type 1 Diabetes Preclinical Program at the Federation of Clinical Immunology Societies (FOCIS) 2022 Annual Meeting
June 22, 2022
 · 
5 min read
Drug Development
Cortexyme Announces Preclinical Data Demonstrating Efficacy of COR803 for the Treatment of Coronavirus Infections
June 21, 2022
 · 
3 min read
Drug Development
Affinivax Presents Data for Enhanced Protection Against Serotype 3 in Next-Generation Pneumococcal Vaccine
June 21, 2022
 · 
5 min read
Drug Development
SQZ Biotechnologies Presents Celiac Disease Tolerizing Antigen Carrier Preclinical Data at 2022 Federation of Clinical Immunology Societies (FOCIS) Annual Meeting
June 21, 2022
 · 
9 min read
Drug Development
3Z closes $2 million funding for preclinical development of novel ADHD and Insomnia therapeutics identified by 3Z´s zebrafish drug discovery platform
June 20, 2022
 · 
2 min read
Drug Development
Avidity Biosciences Supports World Facioscapulohumeral Muscular Dystrophy (FSHD) Day and Presents Preclinical Data from FSHD Program
June 17, 2022
 · 
8 min read
Drug Development
Cyclerion Therapeutics Announces CY6463 Data Demonstrating Improved Cellular Energetics in Preclinical Models of Mitochondrial Disease
June 17, 2022
 · 
5 min read
Drug Development
Kineta Presents New Preclinical Data and Phase 1/2 Clinical Trial Design of KVA12.1 at the Tumor Myeloid-Directed Therapies Summit
June 17, 2022
 · 
7 min read
Drug Development
Cornerstone Pharmaceuticals Announces Published Data on CPI-613® (Devimistat) as an Effective Approach to Targeting Carcinoma Catabolism – UPDATE
June 16, 2022
 · 
3 min read
Drug Development
Cornerstone Pharmaceuticals Announces Published Data on CPI-613® (Devimistat) as an Effective Approach to Targeting Carcinoma Catabolism
June 16, 2022
 · 
3 min read
Drug Development
Biophytis Presents Preclinical Efficacy Data for Sarconeos (BIO101) in Spinal Muscular Atrophy (SMA), a Rare Neuromuscular Disease
June 16, 2022
 · 
4 min read
Drug Development
Lassen Therapeutics Presents New Preclinical Data on IL-11 Receptor-blocking as a Novel Therapeutic Approach for Skin Fibrosis at Keystone Symposia Conference
June 15, 2022
 · 
2 min read
Drug Development
Blue Earth Therapeutics Announces Promising Results of Preclinical Biodistribution and Efficacy Evaluation of 177Lu-rhPSMA-10.1 in Treatment of Prostate Cancer
June 14, 2022
 · 
8 min read
Drug Development
Alpha Cognition Announces Positive Data from Pre-Clinical Studies and Discovery of GEM Combinations with Potential for Neurodegenerative Disease Treatment
June 13, 2022
 · 
7 min read
Business
Startup Vitalunga creates novel oral drug to enable disease-free aging; pre-clinical studies expected to begin in near future
June 13, 2022
 · 
3 min read
Drug Development
Wugen Presents New Preclinical Data Demonstrating Enhanced Anti-Tumor Activity of WU-NK-101 at the European Hematology Association (EHA) 2022 Hybrid Congress
June 10, 2022
 · 
3 min read
Load More